Feedback / Questions
C9ORF72-ALS therapeutic - Locana
https://www.biospace.com/article/releases/locanabio-presents-preclinical-data-from-its-vectorized-snrna-exon-skipping-program-for-dmd-and-cas13d-multi-targeting-program-for-c9orf72-als-at-the-american-society-of-gene-and-cell-therapy-asgct-26th-annual-meeting/
May 16, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next